Clinical Trial Update: Drug-Drug Interaction Study of VCH-222 and Telaprevir in Healthy Subjects [Phase 1]

View source ↗

Summary

A Phase 1 study assessed potential drug-drug interactions between VCH-222 and telaprevir in healthy subjects; the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Telaprevir (telaprevir)
• VCH-222

Snippet

Sponsor: Vertex Pharmaceuticals Incorporated | Conditions: Hepatitis C | Phase 1 | Status: COMPLETED